These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 35219354)

  • 21. Increased expression of long non-coding RNA GLIDR in prostate cancer.
    Zhang Y; Kong Z; Zhang Y; Huang W; Wu H; Wan X; Li Y
    Cancer Biomark; 2017; 19(2):145-150. PubMed ID: 28211799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent scenario of long non-coding RNAs as a diagnostic and prognostic biomarkers of prostate cancer.
    Shukla KK; Misra S; Sankanagoudar S; Sharma H; Choudhary GR; Pareek P; Vishnoi JR; Sharma P
    Urol Oncol; 2020 Dec; 38(12):918-928. PubMed ID: 32622720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long noncoding RNAs: new players in prostate cancer.
    Cheng W; Zhang Z; Wang J
    Cancer Lett; 2013 Oct; 339(1):8-14. PubMed ID: 23856029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Roles of long non-coding RNAs in prostate cancer and their action mechanisms].
    Li ZF; Xiao N; Yao YW; Yao ZF
    Zhonghua Nan Ke Xue; 2022 Dec; 28(12):1129-1135. PubMed ID: 37846635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long Noncoding RNAs as Innovative Urinary Diagnostic Biomarkers.
    Brisotto G; Guerrieri R; Colizzi F; Steffan A; Montico B; Fratta E
    Methods Mol Biol; 2021; 2292():73-94. PubMed ID: 33651353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metastasis-associated long noncoding RNAs in gastrointestinal cancer: Implications for novel biomarkers and therapeutic targets.
    Zhang FF; Luo YH; Wang H; Zhao L
    World J Gastroenterol; 2016 Oct; 22(39):8735-8749. PubMed ID: 27818589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Long non-coding RNAs related to androgen receptor function in prostate cancer: Advances in studies].
    Wang M; Ying J; Zhang M; Liang CZ
    Zhonghua Nan Ke Xue; 2019 Aug; 25(8):739-743. PubMed ID: 32227719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNAs and renal cell carcinoma.
    Fedorko M; Febu ; Bohušová J; Poprach A; Pacík D
    Klin Onkol; 2020; 33(5):340-349. PubMed ID: 33108878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The evolution of long noncoding RNA acceptance in prostate cancer initiation, progression, and its clinical utility in disease management.
    Ramnarine VR; Kobelev M; Gibb EA; Nouri M; Lin D; Wang Y; Buttyan R; Davicioni E; Zoubeidi A; Collins CC
    Eur Urol; 2019 Nov; 76(5):546-559. PubMed ID: 31445843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long Non-Coding RNAs - Current Methods of Detection and Clinical Applications.
    Moráňová L; Bartošík M
    Klin Onkol; 2019; 32(Supplementum 3):65-71. PubMed ID: 31627708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Landscape of Noncoding RNA in Prostate Cancer.
    Hua JT; Chen S; He HH
    Trends Genet; 2019 Nov; 35(11):840-851. PubMed ID: 31623872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of lncRNAs in prostate cancer development and progression.
    Weiss M; Plass C; Gerhauser C
    Biol Chem; 2014 Nov; 395(11):1275-90. PubMed ID: 25153594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The regulatory roles of long noncoding RNAs in the biological behavior of pancreatic cancer.
    Li Y; Yang X; Kang X; Liu S
    Saudi J Gastroenterol; 2019; 25(3):145-151. PubMed ID: 30720003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular and cellular functions of long non-coding RNAs in prostate and breast cancer.
    Zhu YS; Zhu J
    Adv Clin Chem; 2022; 106():91-179. PubMed ID: 35152976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of 10 differently expressed lncRNAs as prognostic biomarkers for prostate adenocarcinoma.
    Wu ZY; Wang SG; Li Q; Zhao QS; Shao MM
    Math Biosci Eng; 2019 Dec; 17(3):2037-2047. PubMed ID: 32233522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of HCG18 and MCM3AP-AS1 That Associate With Bone Metastasis, Poor Prognosis and Increased Abundance of M2 Macrophage Infiltration in Prostate Cancer.
    Chen Y; Chen Z; Mo J; Pang M; Chen Z; Feng F; Xie P; Yang B
    Technol Cancer Res Treat; 2021; 20():1533033821990064. PubMed ID: 33596783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis.
    Huang S; Qing C; Huang Z; Zhu Y
    Diagn Pathol; 2016 Jun; 11(1):49. PubMed ID: 27283598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long Non-Coding RNA as Potential Biomarker for Prostate Cancer: Is It Making a Difference?
    Deng J; Tang J; Wang G; Zhu YS
    Int J Environ Res Public Health; 2017 Mar; 14(3):. PubMed ID: 28272371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Long non-coding RNAs in prostate cancer: An update].
    Wu PG; Zhang YX
    Zhonghua Nan Ke Xue; 2018 Aug; 24(8):735-739. PubMed ID: 30173435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AAT resistance-related AC007405.2 and AL354989.1 as novel diagnostic and prognostic markers in prostate cancer.
    Deng Y; Zhang C; Yu H; Chen G; Peng X; Li Y; Feng Z; Shi W; Bai X; Gou X; Liu N
    Aging (Albany NY); 2024 Apr; 16(8):7249-7266. PubMed ID: 38643469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.